NDC Package 50383-924-93 Buprenorphine Hydrochloride

Tablet Sublingual - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50383-924-93
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Buprenorphine Hydrochloride
Non-Proprietary Name:
Buprenorphine Hydrochloride
Substance Name:
Buprenorphine Hydrochloride
Usage Information:
Buprenorphine sublingual tablets is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.
11-Digit NDC Billing Format:
50383092493
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 351264 - buprenorphine HCl 2 MG Sublingual Tablet
  • RxCUI: 351264 - buprenorphine 2 MG Sublingual Tablet
  • RxCUI: 351264 - buprenorphine 2 MG (as buprenorphine HCl 2.16 MG) Sublingual Tablet
  • RxCUI: 351265 - buprenorphine HCl 8 MG Sublingual Tablet
  • RxCUI: 351265 - buprenorphine 8 MG Sublingual Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Akorn Operating Company Llc (dba Akorn)
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Sublingual - Administration beneath the tongue.
  • DEA Schedule:
    Schedule III (CIII) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA090622
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-24-2010
    End Marketing Date:
    03-31-2025
    Exclude Flag:
    N

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50383-924-93?

    The NDC Packaged Code 50383-924-93 is assigned to a package of 30 tablet in 1 bottle of Buprenorphine Hydrochloride, a human prescription drug labeled by Akorn Operating Company Llc (dba Akorn). The product's dosage form is tablet and is administered via sublingual form.

    Is NDC 50383-924 included in the NDC Directory?

    Yes, Buprenorphine Hydrochloride with product code 50383-924 is active and included in the NDC Directory. The product was first marketed by Akorn Operating Company Llc (dba Akorn) on September 24, 2010.

    What is the NDC billing unit for package 50383-924-93?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 50383-924-93?

    The 11-digit format is 50383092493. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250383-924-935-4-250383-0924-93